Full-Time

Supv – R&D Sample Mgmt

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions

Biotechnology
Healthcare

Compensation Overview

$74.8k - $93.5kAnnually

Junior, Mid

Austin, TX, USA

Category
Lab & Research
Life Sciences
Medical Research
Required Skills
SQL
Excel/Numbers/Sheets
Requirements
  • Bachelor’s, or equivalent degree in a scientific discipline.
  • Demonstrated knowledge of GxP and ICH requirements and best practices.
  • At least 2 years of hands-on biobanking experience in industry setting.
  • Experience working in a clinical or biological laboratory.
  • Basic knowledge of LIMS/database query tools with Microsoft Excel and SQL experience preferred.
Responsibilities
  • Responsible for day-to-day staffing/scheduling/setting up sample management schedules.
  • Main point of contact for sample management related inquiries.
  • Coordinate incoming and outgoing compound shipments to/from CROs, partners and collaborators.
  • Manage the receipt, registration, storage and inventory of samples for R&D and fulfill interdepartmental sample requests.
  • Identify, label, and keep accurate sample records in LIMS/database & reconcile sample inventory periodically.
  • Assist the manager on training of Sample Management team and monitor the training progress of new hires.
  • Ensure accurate, ethical, and appropriate management of samples in compliance with all applicable federal regulations.
  • Monitors team members to ensure adherence to SOPs and lab safety procedures.

Natera specializes in genetic testing and diagnostics, focusing on advanced testing solutions for various medical needs. Their main technology is cell-free DNA (cfDNA) testing, which analyzes small DNA fragments in the blood to detect molecular residual disease (MRD) in cancer patients, aiding in treatment decisions. They also offer the Signatera test, a custom ctDNA test for cancer patients, accessible remotely. In addition to oncology, Natera provides testing for organ health in transplant patients and offers tests for women's health, including family planning and prenatal screening. Their Panorama NIPT has conducted over 2 million tests. Natera's business model involves selling testing kits and services to healthcare providers and patients, often reimbursed by insurance, and they provide genetic counseling services for personalized patient support.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

12%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • Growing personalized medicine trend enhances relevance of Natera's custom ctDNA tests.
  • Rise in telehealth services expands reach of Natera's genetic counseling offerings.

What critics are saying

  • Increased competition in cfDNA testing market may impact Natera's market share.
  • Ongoing investigations into alleged deceptive practices could affect investor confidence.
  • Rapid advancements in genetic testing technology risk making current offerings obsolete.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Natera's fetal RhD test addresses RhIg shortages, offering early gestation testing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks